Table 2 Demographic and clinical features after propensity score matching.
Total n = 40 | LR group n = 20 | TACE group n = 20 | Standardized mean difference (%) | p value | |
|---|---|---|---|---|---|
Age (year) | 65.5 (29–80) | 66.5 (42–80) | 64.5 (29–77) | 10 | 0.533 |
Sex, n (%) | |||||
Male | 24 (60) | 12 (60) | 12 (60) | 0.1 | 1 |
Female | 16 (40) | 8 (40) | 8 (40) | ||
Cirrhosis, n (%) | |||||
Yes | 25 (62.5) | 12 (60) | 13 (65) | 10 | 1 |
No | 15 (37.5) | 8 (40) | 7 (35) | ||
Viral status, n (%) | |||||
HCV | 20 (50) | 10 (50) | 10 (50) | 0.1 | 1 |
HBV | 14 (35) | 7 (35) | 7 (35) | ||
Negative | 6 (15) | 3 (15) | 3 (15) | ||
Child–Pugh score, n (%) | |||||
A | 40 (100) | 20 (100) | 20 (100) | 0.1 | - |
B | 0 | 0 | 0 | ||
ECOG status, n (%) | |||||
0 | 39 (97.5) | 20 (100) | 19 (95) | 21 | 1 |
1 | 1 (2.5) | 0 | 1 (5) | ||
AFP (ng/mL) | 347.5 (4–9898) | 131.5 (4–5543) | 481.5 (20–9898) | 10 | 0.086 |
Lesion number, n (%) | |||||
Solitary | 36 (90) | 18 (90) | 18 (90) | 0.1 | 1 |
Multiple | 4 (10) | 2 (10) | 2 (10) | ||
Distribution, n (%) | |||||
Unilobar | 40 (100) | 20 (100) | 20 (100) | 0.1 | - |
Bilobar | 0 | 0 | 0 | ||
Major lesion size (cm), n (%) | |||||
10–14.9 | 24 (60) | 12 (60) | 12 (60) | 0.1 | 1 |
15–19.9 | 12 (30) | 6 (30) | 6 (30) | ||
≥ 20 | 4 (10) | 2 (10) | 2 (10) | ||
Albumin (g/L) | 40 (26–51) | 41 (26–51) | 39 (33–45) | 6 | 0.854 |
Total bilirubin (mmol/L) | 14 (5–39) | 14 (6–36) | 14 (5–39) | 1 | 0.952 |
ALT (IU/L) | 49 (6–206) | 43 (16–166) | 54 (6–206) | 1 | 0.839 |
γGT (IU/L) | 136.5 (16–470) | 97 (16–470) | 158 (29–272) | 3 | 0.675 |
PT | 12 (10–15) | 12 (11–15) | 12 (10–15) | 8 | 0.677 |
